Search

Search Constraints

You searched for: Author/Creator Colas, Eva

Search Results

1. 2022-RA-997-ESGO Lung recurrence of endometrial adenocarcinoma: impact of molecular profile and role of local therapies on prognosis. (20th October 2022)

2. 37/#877 Hormonal biomarkers remain prognostic relevant within the molecular classification in endometrial cancer. (4th December 2022)

3. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early‐stage endometrioid endometrial cancer. Issue 4 (23rd January 2017)

4. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. Issue 3 (1st March 2018)

5. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. Issue 3 (March 2018)

6. Advances in endometrial cancer protein biomarkers for use in the clinic. (2nd January 2018)

7. Annexin‐A2 as predictor biomarker of recurrent disease in endometrial cancer. Issue 8 (29th September 2014)

8. Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols. Issue 1 (December 2016)

9. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways. Issue 6 (7th November 2017)

10. Molecular diagnosis of endometrial cancer from uterine aspirates. Issue 10 (21st June 2013)